DNA Methylation of RUNX3 in Papillary Thyroid Cancer
의약학 > 내과학
( Hee Ja Ko ) , ( Bo Yeon Kim ) , ( Chan Hee Jung ) , ( Sung Wan Chun ) , ( Ji Oh Mok ) , ( Yeo Joo Kim ) , ( Hyeong Kyu Park ) , ( Chul Hee Kim ) , ( Sang Jin Kim ) , ( Dong Won Byun ) , ( Kyo Il Suh ) , ( Myung Hi Yoo ) , ( Sung Gu Kang )
The Korean Journal of Internal Medicine 2012년, 제27권 제4호, 407~410페이지(총4페이지)
42847643.pdf [무료 PDF 뷰어 다운로드]
  • ※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
  • 구매가격
    30원 (구매자료 3% 적립)
    이메일 발송  스크랩 하기
    자료 다운로드  네이버 로그인
    Background/Aims: The relationship between Runt-related transcription factor 3 (RUNX3) gene inactivation and various solid tumors has been reported; however, little information is available about RUNX3 in thyroid cancers. Methods: We evaluated the DNA methylation of RUNX3 in 13 papillary thyroid cancer tissues and four thyroid cancer cell lines. Additionally, using reverse transcriptase-polymerase chain reaction, we analyzed RUNX3 gene expression in several thyroid cancer cell lines after treating with the demethylating agent 5-aza-2``-deoxycytidine (DAC). Results: RUNX3 was hypermethylated in many thyroid cancer cell lines and in 10 of the 12 papillary thyroid cancer tissues. Treatment with DAC increased the expression of RUNX3 in some thyroid cancer cell lines. Conclusions: We suggest that RUNX3 is associated with thyroid carcinogenesis, and RUNX3 methylation is a potentially useful diagnostic marker for papillary thyroid cancer.
    사업자등록번호 220-87-87785 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.070-8809-9397
    개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1765호 이메일 help@reportshop.co.kr
    copyright (c) 2009 happynlife. steel All reserved.